Latest Press Release on Pharmaceutical

ScinoPharm Announces SafeBridge Potent Compound Safety Certification
TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/ -- ScinoPharm, a leading global supplier of active pharmaceutical ingredients (APIs), announced that its Tainan facility has received the Potent Compound Safety Certification from SafeBridge(R) Consultants, Inc. T...

---

Omnicare Declares Quarterly Cash Dividend
COVINGTON, Ky. - The Board of Directors of Omnicare, Inc. (NYSE:OCR), a leading provider of pharmaceutical care for the elderly, declared today a quarterly cash dividend of 2.25 cents ($0.0225) per share on its common stock. The dividend is payable December 21, 2009 to stockholders of record

---

West Announces Management Change
LIONVILLE, Pa., Nov. 23 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the company's Chief Operating Officer Matthew T. Mullarkey has left the company by mutual agreement. Company President and former Chief Operating Officer Steven ...

---

Spherix Announces the Closing of $6.3 Million Registered Direct Offering
BETHESDA, Md., Nov. 19 -- Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, announced...

---

Spherix Announces Results of Annual Shareholders Meeting
BETHESDA, Md., Nov. 19 -- Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced the resul...

---

Acurian Announces Licensing Agreement with i3 for Clinical Research Site Selection Services
HORSHAM, Pa. - Acurian, Inc., a leading, full-service provider of patient recruitment and retention solutions, announced today that it entered into an agreement with pharmaceutical services company i3 to offer improved site identification and selection to its customers. Through the agreement

---

Pharmaceutical Companies Don't Expect Industry Increase With Health Care Reform
WASHINGTON, Nov. 19 /PRNewswire-USNewswire/ -- A recent Reuters article reported that America's pharmaceutical research and biotechnology companies don't expect an industr...

---

Emetrol(R) Sponsors WebMD Tips on Treating Nausea for Moms During 2009-2010 Flu Season
SARASOTA, Fla., Nov. 19 /PRNewswire/ -- WellSpring Pharmaceutical Corporation is sponsoring a multi-part, WebMD section for mothers with advice about treating nausea and vomiting during the flu season. "Nausea & Vomiting: A Mom's Guide for the Family" (

---

Reflect Scientific Enters Cooperative Agreement With Resonon
OREM, UT -- 11/19/09 -- Reflect Scientific, Inc. (OTCBB: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical, medical, industrial and transportation industries, announced the Company has entered into a collabora..

---

US panel backs Pfizer’s new vacine. Reported by Chartpoppers.com
(EMAILWIRE.COM, November 19, 2009 ) Point Roberts, WA - Chartpoppers.com announces an investment report featuring company Pfizer Inc. (NYSE:PFE)Pfizer Inc. is a research-based, global pharmaceutical company. The Company discovers, develops, manufact..

---

BioMarin to Present at the NASDAQ OMX 23rd Investor Program
NOVATO, Calif., Nov. 24 -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company update at the NASDAQ OMX 23rd Investor Program in London on Tuesday, December 1, 2009 at ...

---

Medifacts Inks $1.6 Million Diabetes Study with Top Five Pharmaceutical Company
ROCKVILLE, Md. & LANGENFELD, Germany - MEDIFACTS INTERNATIONAL, INC. one of the largest global providers of noninvasive cardiac diagnostic services today announced the award of a $1.6 million contract with a top five pharmaceutical company to provide comprehensive cardiac safety and effi

---

NIPTE Receives FDA Contract to Develop Educational Program in State-of-the-Art Pharmaceutical Manufacturing Science for FDA Reviewers
WEST LAFAYETTE, Ind. - The U.S. Food and Drug Administration (FDA) has awarded the National Institute for Pharmaceutical Technology and Education, Inc. (NIPTE) a $652,000 two-year contract to develop and deliver a professional development program to help to ensure that FDA reviewers are curr

---

Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA
BEIJING, Nov. 24 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescriptions drugs and licensed national seller of pharmaceutical pr...

---

Radient Pharmaceuticals Announces Third Quarter 2009 Financial Results
TUSTIN, CA -- 11/24/09 -- Radient Pharmaceuticals Corporation (NYSE Amex: RPC), a US-based pharmaceutical company that specializes in In Vitro Diagnostic (IVD) cancer tests and cell-renewing skin care products, announced today unaudited results and..

---

Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman
CAMBRIDGE, Mass., Nov. 23 /PRNewswire/ -- Ligon Discovery, Inc., which uses proprietary small molecule microarray technology to find drugs against high-value targets, today announced the appointment of pharmaceutical industry veteran Errol B. De Souza as Ligon's Executive Chairman o...

---

Salix Pharmaceuticals, Ltd. Completes Sale of 6.325 Million Shares of Common Stock
RALEIGH, N.C. - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP), a specialty pharmaceutical company, today announced it has closed its previously announced public offering of 5,500,000 shares of its common stock at a price of $21.00 per share. On November 18, 2009, Jefferies & Company, In

---

Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase
XI'AN, China, Nov. 24 /PRNewswire-Asia/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food produc...

---

Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace
RALEIGH, N.C., Nov. 24 /PRNewswire/ -- Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry, today announced the launch of a new e-course titled, Hospital Marketplace. The new Hospital Marketplace e-cou...

---

New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS
WASHINGTON, Nov. 24 /PRNewswire-USNewswire/ -- America's pharmaceutical research and biotechnology companies are testing 97 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a new report released today by the Pharmaceutical Research and Manufac...

---

Emisphere Technologies to Present at the New York Society of Security Analysts’ 13th Annual Biotech & Specialty Pharma Investment Conference
CEDAR KNOLLS, N.J. - Emisphere Technologies, Inc. (OTC BB: EMIS), a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and pharmaceutical compounds using its Eligen® Technology, today announced that President and Chief Executive O

---

Large Companies Still Looking for Acquisition Targets, Says Cutting Edge Information
RESEARCH TRIANGLE PARK, NC -- 11/24/09 -- According to pharmaceutical deal makers, the recent round of industry M&A is far from over. In the past year, drug makers' thirst for innovation combined with small companies' dwindling operat..

---

Ohr Pharmaceutical Data Review Supports the Strong Potential of Its Lead Drug OHR/AVR118 for Cachexia
DOVER, DE -- 11/24/09 -- Ohr Pharmaceutical Inc. (OTCBB: OHRP) is developing OHR/AVR118 for treatment of cachexia based on technology acquired earlier this year from Advanced Viral Research Corp. OHR/AVR118 has shown excellent therapeutic efficacy ..

---

China Aoxing Pharmaceutical Company Reports First Quarter 2010 Financial and Operational Results
NEW YORK, NY -- 11/24/09 -- China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management product..

---

Planet Biopharmaceuticals Announces Annual Meeting and Results of Clinical Trials
RIDGEFIELD, CT and LIBERTY, MO -- 11/25/09 -- Planet Biopharmaceuticals, Inc. (PINKSHEETS: PBPH) and its wholly owned subsidiaries (collectively, "Planet"), a specialty pharmaceutical company focused on providing products for allergy and asthma suf..

---